Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06189144
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-09-13
Brief Title:
Testing an Intervention in Irritative Contact Dermatitis
Sponsor:
University of Split School of Medicine
Organization:
University of Split School of Medicine
Study Overview
Official Title:
Testing the Effectiveness of an Intervention in Irritative Contact DermatitisRandomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An eczematous reaction is an inflammatory intolerance response of the skin In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness itchiness and lichenification Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells which trigger inflammation by activation of the innate immune system
Detailed Description:
An eczematous reaction is an inflammatory intolerance response of the skin In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness itchiness and lichenification Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells which trigger inflammation by activation of the innate immune system Therefore the aim of this study was to see if omega cream as proposed by its mechanism of action could improve SLS induced contact dermatitis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None